Answer
Prolonged use of the Panpharma UK Ltd ertapenem sodium product may cause overgrowth of non-susceptible organisms, leading to superinfection; repeated evaluation of the patient's condition is essential, and appropriate measures should be taken if superinfection occurs during therapy.
Sources for this answer
- Ertapenem 1g Powder for Concentrate for Solution for InfusionPanpharma UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked